Rilmenidine |
An antihypertensive agent; binds to imidazole receptors in bovine rostral… |
100 mg |
32879-100 |
More Info
|
Rilmenidine |
An antihypertensive agent; binds to imidazole receptors in bovine rostral… |
500 mg |
32879-500 |
More Info
|
Rilmenidine-d4 |
An internal standard for the quantification of rilmenidine by GC- or LC-MS |
1 mg |
31691-1 |
More Info
|
Rilmenidine-d4 |
An internal standard for the quantification of rilmenidine by GC- or LC-MS |
500 µg |
31691-500 |
More Info
|
Rilmenidine (hemifumarate) |
An antihypertensive agent; binds to imidazole receptors in bovine rostral… |
1 mg |
16988-1 |
More Info
|
Rilmenidine (hemifumarate) |
An antihypertensive agent; binds to imidazole receptors in bovine rostral… |
10 mg |
16988-10 |
More Info
|
Rilmenidine (hemifumarate) |
An antihypertensive agent; binds to imidazole receptors in bovine rostral… |
5 mg |
16988-5 |
More Info
|
Rilmenidine (hemifumarate) |
An antihypertensive agent; binds to imidazole receptors in bovine rostral… |
50 mg |
16988-50 |
More Info
|
15(R)-Iloprost |
The inverted C-15 epimer of iloprost |
1 mg |
10043-1 |
More Info
|
15(R)-Iloprost |
The inverted C-15 epimer of iloprost |
10 mg |
10043-10 |
More Info
|
15(R)-Iloprost |
The inverted C-15 epimer of iloprost |
5 mg |
10043-5 |
More Info
|
15(R)-Iloprost |
The inverted C-15 epimer of iloprost |
500 µg |
10043-500 |
More Info
|
16(R)-Iloprost |
An isomer of iloprost that inhibits platelet aggregation with an IC 50 val… |
1 mg |
13076-1 |
More Info
|
16(R)-Iloprost |
An isomer of iloprost that inhibits platelet aggregation with an IC 50 val… |
5 mg |
13076-5 |
More Info
|
16(R)-Iloprost |
An isomer of iloprost that inhibits platelet aggregation with an IC 50 val… |
500 µg |
13076-500 |
More Info
|
Rilpivirine |
A non-nucleoside reverse transcriptase inhibitor; inhibits growth of wild-… |
1 mg |
21559-1 |
More Info
|
Rilpivirine |
A non-nucleoside reverse transcriptase inhibitor; inhibits growth of wild-… |
10 mg |
21559-10 |
More Info
|
Rilpivirine |
A non-nucleoside reverse transcriptase inhibitor; inhibits growth of wild-… |
25 mg |
21559-25 |
More Info
|
Rilpivirine |
A non-nucleoside reverse transcriptase inhibitor; inhibits growth of wild-… |
5 mg |
21559-5 |
More Info
|
Rilpivirine-d6 (hydrochloride) |
An internal standard for the quantification of rilpivirine by GC- or LC-MS… |
1 mg |
26520-1 |
More Info
|
Rilpivirine-d6 (hydrochloride) |
An internal standard for the quantification of rilpivirine by GC- or LC-MS… |
500 µg |
26520-500 |
More Info
|
Riluzole |
A calcium channel inhibitor; selective for the voltage-gated calcium chann… |
10 mg |
35833-10 |
More Info
|
Riluzole |
A calcium channel inhibitor; selective for the voltage-gated calcium chann… |
100 mg |
35833-100 |
More Info
|
Riluzole |
A calcium channel inhibitor; selective for the voltage-gated calcium chann… |
250 mg |
35833-250 |
More Info
|
Riluzole |
A calcium channel inhibitor; selective for the voltage-gated calcium chann… |
50 mg |
35833-50 |
More Info
|
Riluzole-13C,15N2 |
An internal standard for the quantification of riluzole by GC- or LC-MS |
1 mg |
25361-1 |
More Info
|
Riluzole (hydrochloride) |
A benzothiazole derivative with anti-excitotoxic effects that acts by bloc… |
10 mg |
14577-10 |
More Info
|
Riluzole (hydrochloride) |
A benzothiazole derivative with anti-excitotoxic effects that acts by bloc… |
50 mg |
14577-50 |
More Info
|
Rimantadine (hydrochloride) |
A derivative of amantadine with antiviral activity; inhibits recombinant i… |
100 mg |
23838-100 |
More Info
|
Rimantadine (hydrochloride) |
A derivative of amantadine with antiviral activity; inhibits recombinant i… |
25 mg |
23838-25 |
More Info
|
Rimantadine (hydrochloride) |
A derivative of amantadine with antiviral activity; inhibits recombinant i… |
250 mg |
23838-250 |
More Info
|
Rimantadine (hydrochloride) |
A derivative of amantadine with antiviral activity; inhibits recombinant i… |
50 mg |
23838-50 |
More Info
|
Rimiducid |
A CID for FKBPF36V fusion proteins; selectively binds to FKBPF36V over wil… |
1 mg |
35303-1 |
More Info
|
Rimiducid |
A CID for FKBPF36V fusion proteins; selectively binds to FKBPF36V over wil… |
10 mg |
35303-10 |
More Info
|
Rimiducid |
A CID for FKBPF36V fusion proteins; selectively binds to FKBPF36V over wil… |
5 mg |
35303-5 |
More Info
|
Rimonabant |
A CB1 receptor antagonist (Ki = 5.6 nM); selective for CB1 over CB2 recept… |
10 mg |
9000484-10 |
More Info
|
Rimonabant |
A CB1 receptor antagonist (Ki = 5.6 nM); selective for CB1 over CB2 recept… |
25 mg |
9000484-25 |
More Info
|
Rimonabant |
A CB1 receptor antagonist (Ki = 5.6 nM); selective for CB1 over CB2 recept… |
5 mg |
9000484-5 |
More Info
|
Rimonabant |
A CB1 receptor antagonist (Ki = 5.6 nM); selective for CB1 over CB2 recept… |
50 mg |
9000484-50 |
More Info
|
Rimonabant-d10 |
An internal standard for the quantification of rimonabant by GC- or LC-MS |
1 mg |
9001821-1 |
More Info
|
Rimonabant-d10 |
An internal standard for the quantification of rimonabant by GC- or LC-MS |
500 µg |
9001821-500 |
More Info
|
(R)-IMPP |
A cell-permeable inhibitor of PCSK9 secretion (IC50 = 4.8 µM); promo… |
1 mg |
20861-1 |
More Info
|
(R)-IMPP |
A cell-permeable inhibitor of PCSK9 secretion (IC50 = 4.8 µM); promo… |
10 mg |
20861-10 |
More Info
|
(R)-IMPP |
A cell-permeable inhibitor of PCSK9 secretion (IC50 = 4.8 µM); promo… |
25 mg |
20861-25 |
More Info
|
(R)-IMPP |
A cell-permeable inhibitor of PCSK9 secretion (IC50 = 4.8 µM); promo… |
5 mg |
20861-5 |
More Info
|
Riociguat |
A stimulator of sGC; stimulates recombinant sGC in a concentration-depende… |
10 mg |
9000554-10 |
More Info
|
Riociguat |
A stimulator of sGC; stimulates recombinant sGC in a concentration-depende… |
25 mg |
9000554-25 |
More Info
|
Riociguat |
A stimulator of sGC; stimulates recombinant sGC in a concentration-depende… |
5 mg |
9000554-5 |
More Info
|
Riociguat |
A stimulator of sGC; stimulates recombinant sGC in a concentration-depende… |
50 mg |
9000554-50 |
More Info
|
Riociguat-13C-d3 |
An internal standard for the quantification of riociguat by GC- or LC-MS |
1 mg |
25314-1 |
More Info
|
Riociguat-13C-d3 |
An internal standard for the quantification of riociguat by GC- or LC-MS |
500 µg |
25314-500 |
More Info
|
RIPA-56 |
A RIPK1 inhibitor (IC50 = 13 nM); selective for RIPK1 over RIPK3 at 10 &mi… |
10 mg |
33431-10 |
More Info
|
RIPA-56 |
A RIPK1 inhibitor (IC50 = 13 nM); selective for RIPK1 over RIPK3 at 10 &mi… |
25 mg |
33431-25 |
More Info
|
RIPA-56 |
A RIPK1 inhibitor (IC50 = 13 nM); selective for RIPK1 over RIPK3 at 10 &mi… |
5 mg |
33431-5 |
More Info
|
RIPA-56 |
A RIPK1 inhibitor (IC50 = 13 nM); selective for RIPK1 over RIPK3 at 10 &mi… |
50 mg |
33431-50 |
More Info
|
RIPA Buffer Concentrate |
A concentrated buffer solution |
1 ea |
10010263-1 |
More Info
|
Ripasudil (hydrochloride hydrate) |
A ROCK1 and ROCK2 inhibitor (IC50s = 51 and 19 nM, respectively); selectiv… |
1 mg |
19920-1 |
More Info
|
Ripasudil (hydrochloride hydrate) |
A ROCK1 and ROCK2 inhibitor (IC50s = 51 and 19 nM, respectively); selectiv… |
10 mg |
19920-10 |
More Info
|
Ripasudil (hydrochloride hydrate) |
A ROCK1 and ROCK2 inhibitor (IC50s = 51 and 19 nM, respectively); selectiv… |
25 mg |
19920-25 |
More Info
|
Ripasudil (hydrochloride hydrate) |
A ROCK1 and ROCK2 inhibitor (IC50s = 51 and 19 nM, respectively); selectiv… |
5 mg |
19920-5 |
More Info
|
RIPGBM |
A prodrug form of the pro-apoptotic compound cRIPGBM; converted to cRIPGBM… |
1 mg |
27860-1 |
More Info
|
RIPGBM |
A prodrug form of the pro-apoptotic compound cRIPGBM; converted to cRIPGBM… |
10 mg |
27860-10 |
More Info
|
RIPGBM |
A prodrug form of the pro-apoptotic compound cRIPGBM; converted to cRIPGBM… |
5 mg |
27860-5 |
More Info
|
Ripretinib |
A KIT and PDGFRα inhibitor (IC50s = 3 and 3.6 nM, respectively); sel… |
10 mg |
33782-10 |
More Info
|
Ripretinib |
A KIT and PDGFRα inhibitor (IC50s = 3 and 3.6 nM, respectively); sel… |
25 mg |
33782-25 |
More Info
|
Ripretinib |
A KIT and PDGFRα inhibitor (IC50s = 3 and 3.6 nM, respectively); sel… |
5 mg |
33782-5 |
More Info
|
Ripretinib |
A KIT and PDGFRα inhibitor (IC50s = 3 and 3.6 nM, respectively); sel… |
50 mg |
33782-50 |
More Info
|
Risdiplam |
A SMN2 splicing modifier; enhances SMN2 splicing (EC1.5x= 40 nM) and incre… |
1 mg |
29028-1 |
More Info
|
Risdiplam |
A SMN2 splicing modifier; enhances SMN2 splicing (EC1.5x= 40 nM) and incre… |
10 mg |
29028-10 |
More Info
|
Risdiplam |
A SMN2 splicing modifier; enhances SMN2 splicing (EC1.5x= 40 nM) and incre… |
25 mg |
29028-25 |
More Info
|
Risdiplam |
A SMN2 splicing modifier; enhances SMN2 splicing (EC1.5x= 40 nM) and incre… |
5 mg |
29028-5 |
More Info
|
Risedronate (sodium salt) |
An aminobisphosphonate and antimalarial agent that inhibits bone resorptio… |
1 g |
20740-1 |
More Info
|
Risedronate (sodium salt) |
An aminobisphosphonate and antimalarial agent that inhibits bone resorptio… |
250 mg |
20740-250 |
More Info
|
Risedronate (sodium salt) |
An aminobisphosphonate and antimalarial agent that inhibits bone resorptio… |
5 g |
20740-5 |
More Info
|
Risedronate (sodium salt) |
An aminobisphosphonate and antimalarial agent that inhibits bone resorptio… |
500 mg |
20740-500 |
More Info
|
Risperidone |
An atypical antipsychotic; binds to dopamine D2 receptors (Ki = 3 nM) and… |
10 mg |
13629-10 |
More Info
|
Risperidone |
An atypical antipsychotic; binds to dopamine D2 receptors (Ki = 3 nM) and… |
100 mg |
13629-100 |
More Info
|
Risperidone |
An atypical antipsychotic; binds to dopamine D2 receptors (Ki = 3 nM) and… |
50 mg |
13629-50 |
More Info
|
Risperidone-d4 |
An internal standard for the quantification of risperidone by GC- or LC-MS |
1 mg |
10010570-1 |
More Info
|
Risperidone-d4 |
An internal standard for the quantification of risperidone by GC- or LC-MS |
500 µg |
10010570-500 |
More Info
|
Risperidone E-oxime |
An impurity found in risperidone |
1 mg |
22156-1 |
More Info
|
Risperidone E-oxime |
An impurity found in risperidone |
10 mg |
22156-10 |
More Info
|
Risperidone E-oxime |
An impurity found in risperidone |
5 mg |
22156-5 |
More Info
|
Risperidone E-oxime |
An impurity found in risperidone |
500 µg |
22156-500 |
More Info
|
Ristocetin A (sulfate) |
An antibiotic used in the ristocetin cofactor assay and the ristocetin-ind… |
10 mg |
20601-10 |
More Info
|
Ristocetin A (sulfate) |
An antibiotic used in the ristocetin cofactor assay and the ristocetin-ind… |
50 mg |
20601-50 |
More Info
|
Risuteganib (trifluoroacetate salt) |
An anti-integrin peptide; protects against hydroquinone-induced necrosis a… |
1 mg |
33303-1 |
More Info
|
Risuteganib (trifluoroacetate salt) |
An anti-integrin peptide; protects against hydroquinone-induced necrosis a… |
10 mg |
33303-10 |
More Info
|
Risuteganib (trifluoroacetate salt) |
An anti-integrin peptide; protects against hydroquinone-induced necrosis a… |
5 mg |
33303-5 |
More Info
|
RITA |
An inhibitor of p53-HDM-2 interaction; reactivates the tumor suppressor fu… |
1 mg |
10006426-1 |
More Info
|
RITA |
An inhibitor of p53-HDM-2 interaction; reactivates the tumor suppressor fu… |
10 mg |
10006426-10 |
More Info
|
RITA |
An inhibitor of p53-HDM-2 interaction; reactivates the tumor suppressor fu… |
5 mg |
10006426-5 |
More Info
|
RITA |
An inhibitor of p53-HDM-2 interaction; reactivates the tumor suppressor fu… |
50 mg |
10006426-50 |
More Info
|
Ritalinic Acid |
An inactive, major metabolite of methylphenidate; intended for forensic an… |
10 mg |
15915-10 |
More Info
|
Ritalinic Acid |
An inactive, major metabolite of methylphenidate; intended for forensic an… |
5 mg |
15915-5 |
More Info
|
Ritalinic Acid |
An inactive, major metabolite of methylphenidate; intended for forensic an… |
50 mg |
15915-50 |
More Info
|
Ritanserin |
A potent 5-HT2A receptor antagonist; selective for 5-HT2A over 5-HT1 recep… |
10 mg |
21374-10 |
More Info
|
Ritanserin |
A potent 5-HT2A receptor antagonist; selective for 5-HT2A over 5-HT1 recep… |
25 mg |
21374-25 |
More Info
|
Ritanserin |
A potent 5-HT2A receptor antagonist; selective for 5-HT2A over 5-HT1 recep… |
5 mg |
21374-5 |
More Info
|
Ritodrine (hydrochloride) |
A β2-AR agonist; induces relaxation of isolated pig detrusor muscle f… |
1 g |
26084-1 |
More Info
|